Neurelis Announces Positive Results From Phase 1 Pharmacokinetic Study Of NRL-01 (intranasal Diazepam)
Links shared publicly online about this topic.
- 217total visits
Neurelis Announces Positive Results From Phase 1 Pharmacokinetic Study Of NRL-01 (intranasal Diazepam)
View full resource at medicalnewstoday.com
Tags: Anxiety Medication, Valium, Pharmacokinetics
Most Recently Shared on June 15, 2011 at 8:45 am By:
Neurelis Announces Positive Results From Phase 1 Pharmacokinetic Study Of NRL-01 (intranasal Diazepam): Neurelis... http://bit.ly/mGu9Z7
Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis' Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam) - Drugs.com MedNews
drugs.com — “In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I pharmacokinetic s” View full resource at drugs.com
Most Recently Shared on June 22, 2011 at 8:09 pm By:
Drugs and Devices OW OW Health
Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis' Recently Announced Suc... http://bit.ly/kwbs1g #drug
Aegis CNS licensee, Neurelis, Inc., announces exciting Phase I clinical trial results - Drugs.com MedNews
drugs.com — “Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam) Phase 1 clinical trial demonstrated 96 bioavailability of” View full resource at drugs.com
Most Recently Shared on June 16, 2011 at 2:13 pm By:
Drugs and Devices OW OW Health
Aegis CNS licensee, Neurelis, Inc., announces exciting Phase I clinical trial results: Neurelis Announces ... http://bit.ly/lSMMFD #drug
Advertisement
